Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1181)
|
Core Tip (1185)
|
Full Article (HTML) (4098)
|
Full Article (PDF)-777K (632)
|
Audio-357K (37)
|
Peer-Review Report-122K (173)
|
Answering Reviewers-64K (221)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (11603)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications

World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1377)
|
Core Tip (1407)
|
Full Article (HTML) (11688)
|
Figures (1-4) (1581)
|
Full Article (PDF)-948K (1327)
|
Audio-1310K (30)
|
Peer-Review Report-106K (401)
|
Answering Reviewers-19K (259)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (59)
|
Total Visits (25199)
|
Similar Articles (493)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model

World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1293)
|
Core Tip (1301)
|
Full Article (HTML) (4929)
|
Figures (1-2) (320)
|
Tables (1-2) (304)
|
Full Article (PDF)-1246K (718)
|
Audio-442K (32)
|
Peer-Review Report-131K (336)
|
Answering Reviewers-120K (207)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (17607)
|
Similar Articles (15)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1183)
|
Core Tip (1189)
|
Full Article (HTML) (3819)
|
Figures (1-3) (333)
|
Tables (1-1) (315)
|
Full Article (PDF)-814K (528)
|
Audio-757K (21)
|
Peer-Review Report-105K (257)
|
Answering Reviewers-109K (228)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (16051)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1255)
|
Core Tip (1280)
|
Full Article (HTML) (3857)
|
Tables (1-3) (285)
|
Full Article (PDF)-799K (494)
|
Audio-1969K (21)
|
Peer-Review Report-132K (234)
|
Answering Reviewers-50K (204)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (14151)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open